Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Microbiologics Debuts New Molecular Standards Product Line - Helix Elite™

Published: Tuesday, November 19, 2013
Last Updated: Tuesday, November 19, 2013
Bookmark and Share
Company unveils Helix Elite™ at the Association for Molecular Pathology’s Annual Meeting in Phoenix.

Microbiologics debuts its first molecular product line, Helix Elite™. These molecular standards are intended to facilitate the development, validation, and monitoring of molecular assays.

The Helix Elite™ molecular product line currently includes 13 molecular standards for microorganisms that are difficult to grow or cannot be cultured such as Cryptosporidium and Norovirus. Microbiologics has unveiled Helix Elite™ at the Association for Molecular Pathology’s Annual Meeting in Phoenix, AZ.

Helix Elite™ is the first product available from Microbiologics’ newly-formed Molecular Products and Services Division, led by Brian Beck, Vice President Molecular Products and Services.

These synthetic standards are developed using a unique patented bioinformatic algorithm that combines the genetic diversity of diagnostic sequences from the target organism.

Helix Elite™ molecular standards can be used as internal or external positive controls in a defined reaction or spiked into matrices and are applicable for a broad range of assays and instruments.

According to Beck, “The Helix Elite™ molecular standards are a safe alternative to using infectious materials that are otherwise hard to access.”

Microbiologics’ CEO Brad Goskowicz commented, “Microbiologics is leveraging its experience as a global provider of microbial cultures and reagents to provide innovative products of the highest quality to support molecular diagnostics. With the addition of Helix Elite™, Microbiologics is now positioned to offer a full-line of controls, from microorganisms and attenuated strains to genomic and synthetic molecular standards.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
Clamping Down on Biomolecules
Physicists have developed a novel nanotool that provides a means of characterizing the mechanical properties of biomolecules.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos